VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Positioning immunotherapies in the changing paradigm of myeloma treatment

Meral Beksac, MD, Ankara University School of Medicine, Ankara, Turkey, explores how to sequence immunotherapies in the evolving treatment landscape of multiple myeloma, including the use of anti-CD38 monoclonal antibodies at diagnosis which has shown to improve prognosis, as well as bi-specific antibodies, antibody-drug conjugates and CAR T-cells targeting BCMA. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter